PDF herunterladen
Int J Sports Med 2004; 25(8): 588-593
DOI: 10.1055/s-2004-821304
Clinical Sciences

© Georg Thieme Verlag KG Stuttgart · New York

Treatment of Muscle Injuries by Local Administration of Autologous Conditioned Serum: A Pilot Study on Sportsmen with Muscle Strains

T. Wright-Carpenter1 , 3 , P. Klein2 , P. Schäferhoff2 , H. J. Appell3 , L. M. Mir1 , P. Wehling4
  • 1UMR 8121 CNRS, Institut Gustave-Roussy, Villejuif, France
  • 2MediaPark Clinic for Sports Medicine & Orthopaedics, Köln, Germany
  • 3Department of Physiology & Anatomy, German Sport University, Köln, Germany
  • 4Orthopaedics and Neurosurgery Clinic, Düsseldorf, Germany
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. September 2004 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Muscle injuries represent a major part of sports injuries and are a challenging problem in traumatology. Strain injuries are the most common muscle injuries after contusions. These injuries can lead to significant pain and disability causing time to be lost to training and competition. Despite the frequency of strain injuries the treatment available is limited and is generally not sufficient to enhance muscle regeneration efficiently when fast resumption of sport activity is a primary target. A number of growth factors play a specific role in regeneration and it has been proven that a previously described method of physically and chemically stimulating whole blood (to produce autologous conditioned serum) induces concentration increases in FGF-2, HGF, and TGF-β1. A preliminary study was conducted on muscle strain injuries in professional sportsmen receiving either: 1. autologous conditioned serum (ACS) or 2. Actovegin/Traumeel® treatment as control. Assessment of recovery from injury was done by: 1. sport professional's ability to participate to 100 % under competition conditions in their respective sport and 2. MRI analysis. A significant difference in the recovery time from injury was demonstrated: 16.6 ± 0.9 in the ACS treated instead of 22.3 ± 1.2 (mean ± SEM) days in the Actovegin/Traumeel® control group (p = 0.001). MRI analysis supported the observed acceleration of the lesion recovery time. We conclude that ACS injection is a promising approach to reduce the time to recovery from muscle injury.

Key words

Growth factors - regeneration - FGF-2 - skeletal muscle

References

  • 1 Allen R E, Boxhorn L K. Regulation of skeletal muscle satellite cell proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor I, and fibroblast growth factor.  J Cell Physiol. 1989;  138 311-315
    CrossrefPubMedSuche in Google Scholar
  • 2 Allen R E, Dodson M V, Luiten L S. Regulation of skeletal muscle satellite cell proliferation by bovine pituitary fibroblast growth factor.  Exp Cell Res. 1984;  152 154-160
    CrossrefPubMedSuche in Google Scholar
  • 3 Allen R E, Sheehan S M, Taylor R G, Kendall T L, Rice G M. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro.  J Cell Physiol. 1995;  165 307-312
    CrossrefPubMedSuche in Google Scholar
  • 4 Best T M. Soft-tissue injuries and muscle tears.  Clin Sports Med. 1997;  16 419-434
    PubMedSuche in Google Scholar
  • 5 Bischoff R. Chemotaxis of skeletal muscle satellite cells.  Dev Dyn. 1997;  208 505-515
    CrossrefPubMedSuche in Google Scholar
  • 6 Canale S T, Cantler E D, Sisk T D, Freeman B L. A chronicle of injuries of an American intercollegiate football team 3rd.  Am J Sports Med. 1981;  9 384-389
    PubMedSuche in Google Scholar
  • 7 Garrett Jr W E. Muscle strain injuries.  Am J Sports Med. 1996;  24 S2-8
    CrossrefPubMedSuche in Google Scholar
  • 8 Garrett Jr W E. Muscle strain injuries: clinical and basic aspects.  Med Sci Sports Exerc. 1990;  22 436-443
    PubMedSuche in Google Scholar
  • 9 Grunitz B, Krause W. On the application of Traumeel ointment in the orthopedic clinic.  Dt Med J. 1968;  19 245-248
    PubMedSuche in Google Scholar
  • 10 Harrington M A, Daub R, Song A, Stasek J, Garcia J G. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures.  Cell Growth Differ. 1992;  3 241-248
    PubMedSuche in Google Scholar
  • 11 Husmann I, Soulet L, Gautron J, Martelly I, Barritault D. Growth factors in skeletal muscle regeneration.  Cytokine Growth Factor Rev. 1996;  7 249-258
    CrossrefPubMedSuche in Google Scholar
  • 12 Jarvinen T A, Kaariainen M, Jarvinen M, Kalimo H. Muscle strain injuries.  Curr Opin Rheumatol. 2000;  12 155-161
    CrossrefPubMedSuche in Google Scholar
  • 13 Joseph-Silverstein J, Consigli S A, Lyser K M, Ver Pault C. Basic fibroblast growth factor in the chick embryo: immunolocalization to striated muscle cells and their precursors.  J Cell Biol. 1989;  108 2459-2466
    CrossrefPubMedSuche in Google Scholar
  • 14 Kasemkijwattana C, Menetrey J, Bosch P, Somogyi G, Moreland M S, Fu F H, Buranapanitkit B, Watkins S S, Huard J. Use of growth factors to improve muscle healing after strain injury.  Clin Orthop. 2000;  (370) 272-285
    PubMedSuche in Google Scholar
  • 15 Kasemkijwattana C, Menetrey J, Somogyl G, Moreland M S, Fu F H, Buranapanitkit B, Watkins S C, Huard J. Development of approaches to improve the healing following muscle contusion.  Cell Transplant. 1998;  7 585-598
    PubMedSuche in Google Scholar
  • 16 Lefaucheur J P, Sebille A. Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I.  J Neuroimmunol. 1995;  57 85-91
    CrossrefPubMedSuche in Google Scholar
  • 17 Meijer H, Reinecke J, Becker C, Tholen G, Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction.  Inflamm Res. 2003;  52 404-407
    CrossrefPubMedSuche in Google Scholar
  • 18 Pfister A, Koller W. Treatment of fresh muscle injury.  Sportverletz Sportschaden. 1990;  4 41-44
    Thieme ConnectPubMedSuche in Google Scholar
  • 19 Pomeranz S J, Heidt Jr R S. MR imaging in the prognostication of hamstring injury. Work in progress.  Radiology. 1993;  189 897-900
    CrossrefPubMedSuche in Google Scholar
  • 20 Sheehan S M, Allen R E. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor.  J Cell Physiol. 1999;  181 499-506
    CrossrefPubMedSuche in Google Scholar
  • 21 Sheehan S M, Tatsumi R, Temm-Grove C J, Allen R E. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro.  Muscle Nerve. 2000;  23 239-245
    PubMedSuche in Google Scholar
  • 22 Tidball J G. Inflammatory cell response to acute muscle injury.  Med Sci Sports Exerc. 1995;  27 1022-1032
    PubMedSuche in Google Scholar
  • 23 Wright-Carpenter T, Opolon P, Appell H J, Meijer H, Wehling P, Mir L M. Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model.  Int J Sports Med. 2004;  25 583-588
    PubMedSuche in Google Scholar
  • 24 Yablonka-Reuveni Z, Seger R, Rivera A J. Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats.  J Histochem Cytochem. 1999;  47 23-42
    PubMedSuche in Google Scholar
  • 25 Zarins B, Ciullo J V. Acute muscle and tendon injuries in athletes.  Clin Sports Med. 1983;  2 167-182
    PubMedSuche in Google Scholar

L. M. Mir

Laboratory of Vectorology and Gene Transfer, UMR 8121 CNRS - Institut Gustave Roussy

39, rue Camille Desmoulins

94805 Villejuif Cedex

France

Telefon: + 33(0)142114792

Fax: + 33 (0) 1 42 11 52 45

eMail: luismir@igr.fr